Coherus Oncology (CHRS) Total Debt (2013 - 2026)
Coherus Oncology's Total Debt was $37.25 million in Q2 2026, up 1.0% from $36.87 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Total Debt (2013 - 2026) Analysis & Trends
At the end of FY2025, Total Debt at Coherus Oncology came in at $37.05 million, up 1.0% from FY2024.
- Total Debt shows a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
- In earlier years, Total Debt was $36.7 million in FY2024 (-85.1%), $246.48 million in FY2023 (+0.4%), $245.48 million in FY2022 (+225.1%) and $75.51 million in FY2021 (+1.4%).
- The Q2 2026 figure marks the highest quarterly Total Debt since Q1 2024.
- Compared with a year earlier, Total Debt has increased for five straight quarters, with an average decline of 31.3% over the last eight quarters.
- The best year-over-year quarter for Total Debt over five years was Q4 2022 (growth of 225.1%); the worst was Q2 2024 (a decline of 85.1%).
- Per Business Quant data, CHRS's Total Debt in the three quarters before Q2 2026 was $37.15 million (Q1 2026), $37.05 million (Q4 2025) and $36.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 37.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.25 Mn |
| Mar 31, 2026 | 37.15 Mn |
| Dec 31, 2025 | 37.05 Mn |
| Sep 30, 2025 | 36.96 Mn |
| Jun 30, 2025 | 36.87 Mn |
| Mar 31, 2025 | 36.78 Mn |
| Dec 31, 2024 | 36.70 Mn |
| Sep 30, 2024 | 36.62 Mn |
| Jun 30, 2024 | 36.54 Mn |
| Mar 31, 2024 | 247.45 Mn |
| Dec 31, 2023 | 246.48 Mn |
| Sep 30, 2023 | 246.22 Mn |
| Jun 30, 2023 | 245.96 Mn |
| Mar 31, 2023 | 245.72 Mn |
| Dec 31, 2022 | 245.48 Mn |
| Sep 30, 2022 | 245.25 Mn |
| Jun 30, 2022 | 196.04 Mn |
| Mar 31, 2022 | 195.85 Mn |
| Dec 31, 2021 | 75.51 Mn |
| Sep 30, 2021 | 156.21 Mn |
API Access
Coherus Oncology Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();